X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4204) 4204
Magazine Article (90) 90
Newspaper Article (83) 83
Book Chapter (37) 37
Dissertation (26) 26
Newsletter (18) 18
Book / eBook (7) 7
Reference (7) 7
Web Resource (7) 7
Conference Proceeding (6) 6
Publication (4) 4
Transcript (2) 2
Book Review (1) 1
Journal / eJournal (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2984) 2984
off-label use (2317) 2317
female (1188) 1188
male (1093) 1093
off-label (689) 689
pharmacology & pharmacy (643) 643
child (630) 630
middle aged (593) 593
off-label prescribing (564) 564
children (550) 550
adult (546) 546
treatment outcome (525) 525
aged (518) 518
pediatrics (506) 506
adolescent (484) 484
united states (484) 484
drugs (479) 479
retrospective studies (368) 368
off-label use - statistics & numerical data (351) 351
drug therapy (335) 335
medicine, general & internal (335) 335
child, preschool (331) 331
abridged index medicus (326) 326
infant (317) 317
safety (301) 301
drug approval (295) 295
laws, regulations and rules (291) 291
pharmaceutical industry (290) 290
analysis (284) 284
infant, newborn (283) 283
usage (282) 282
off-label use - legislation & jurisprudence (266) 266
double-blind (252) 252
prescription drugs (251) 251
psychiatry (239) 239
health aspects (233) 233
medicine & public health (224) 224
aged, 80 and over (223) 223
risk factors (221) 221
patients (218) 218
care and treatment (213) 213
research (211) 211
united states food and drug administration (211) 211
young adult (210) 210
efficacy (206) 206
therapy (203) 203
clinical trials (202) 202
cardiac & cardiovascular systems (191) 191
surgery (186) 186
drug labeling (183) 183
management (183) 183
internal medicine (177) 177
oncology (169) 169
clinical neurology (168) 168
medicine (167) 167
pharmacology (167) 167
prospective studies (167) 167
practice patterns, physicians' - statistics & numerical data (165) 165
antipsychotic agents - therapeutic use (155) 155
animals (153) 153
risk assessment (152) 152
physicians (150) 150
evidence-based medicine (148) 148
prevalence (143) 143
time factors (136) 136
fda approval (135) 135
dermatology (134) 134
studies (133) 133
pregnancy (128) 128
practice patterns, physicians (126) 126
bevacizumab (123) 123
dosage and administration (123) 123
infants (123) 123
marketing (123) 123
prescribing (122) 122
medical research (121) 121
risk (121) 121
public, environmental & occupational health (119) 119
medicines (118) 118
mortality (118) 118
age factors (117) 117
practice guidelines as topic (117) 117
cancer (115) 115
cross-sectional studies (112) 112
drug dosages (110) 110
pharmacy (110) 110
psychotropic drugs (110) 110
labeling (107) 107
outcomes (107) 107
prescription writing (107) 107
registries (107) 107
drug prescriptions (106) 106
drug utilization (106) 106
hospitals (105) 105
randomized controlled trials as topic (105) 105
drug use (103) 103
germany (100) 100
trial (100) 100
clinical trials as topic (99) 99
follow-up studies (99) 99
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3989) 3989
German (298) 298
French (94) 94
Spanish (80) 80
Portuguese (59) 59
Dutch (13) 13
Italian (13) 13
Russian (13) 13
Japanese (11) 11
Polish (11) 11
Chinese (10) 10
Czech (6) 6
Korean (6) 6
Danish (5) 5
Hungarian (5) 5
Norwegian (5) 5
Swedish (5) 5
Bulgarian (2) 2
Finnish (1) 1
Hebrew (1) 1
Indonesian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JAMA : the journal of the American Medical Association, ISSN 0098-7484, 03/2020, Volume 323, Issue 19, pp. 1897 - 1898
This Viewpoint uses the absence of known effective treatment for Ebola virus disease to emphasize the costs of off-label and compassionate drug use during an infectious disease outbreak... 
MEDICINE, GENERAL & INTERNAL | CORTICOSTEROID TREATMENT | Off-label prescribing | Discovery and exploration | Epidemics | Antiviral agents | Control | Safety and security measures | United States | Analysis | Clinical trials | Economic aspects | Medical care, Cost of | Testing | COVID-19 | Drug abuse | Randomization | Pandemics | Infectious diseases | Medical treatment | Viral diseases | Viruses | Drug use
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 14, pp. 1427 - 1429
Journal Article
Seminars in nephrology, ISSN 0270-9295, 2015, Volume 35, Issue 5, pp. 509 - 520
Journal Article
Journal Article
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 2018, Volume 131, Issue 6, pp. 1031 - 1038
OBJECTIVE:To characterize recommendations given to pregnant women by Colorado cannabis dispensaries regarding use of cannabis products for nausea during the first trimester of pregnancy... 
OBSTETRICS & GYNECOLOGY | Cross-Sectional Studies | Professional-Patient Relations | Legislation, Drug | Humans | Commerce | Pregnancy Trimester, First | Pregnancy | Medical Marijuana - therapeutic use | Colorado | Adult | Female | Morning Sickness - drug therapy | Nausea - drug therapy | Off-Label Use - statistics & numerical data
Journal Article
British journal of clinical pharmacology, ISSN 1365-2125, 2019, Volume 85, Issue 10, pp. 2446 - 2447
...The review by Borysowski et al does not deal with all of the issues surrounding off‐label use in France. First, the claim “treatment with unproven drugs seems... 
French National Medical Council | EBM | Off‐label use | innovative drugs | ethics | quality of care | Off-label use | Codes of Ethics | Drug Labeling | Off-Label Use | Drugs | Medical care | Innovations | Quality management
Journal Article
Circulation Cardiovascular quality and outcomes, ISSN 1941-7705, 2012, Volume 5, Issue 5, pp. 615 - 621
.... Methods and Results-We used the IMS Health National Disease and Therapeutic Index, a nationally representative audit of office-based providers, to quantify patterns of oral anticoagulant use among... 
Coumarins | Other anticoagulants | Anticoagulants | COST-EFFECTIVENESS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | coumarins | PREVENTION | RISK | STROKE | DABIGATRAN | THERAPY | WARFARIN | anticoagulants | NONVALVULAR ATRIAL-FIBRILLATION | other anticoagulants | ASSOCIATION | Drug Costs | Practice Patterns, Physicians' - economics | United States - epidemiology | Anticoagulants - administration & dosage | Drug Utilization - trends | Humans | Middle Aged | Anticoagulants - economics | Medical Audit | Antithrombins - administration & dosage | Dabigatran | Thromboembolism - epidemiology | Drug Utilization Review | Warfarin - administration & dosage | Preventive Health Services - economics | Atrial Fibrillation - economics | Benzimidazoles - administration & dosage | Thromboembolism - prevention & control | Time Factors | Guideline Adherence - trends | Aged, 80 and over | Ambulatory Care - trends | beta-Alanine - analogs & derivatives | Administration, Oral | Atrial Fibrillation - drug therapy | Preventive Health Services - trends | beta-Alanine - administration & dosage | Health Expenditures | Thromboembolism - economics | Practice Patterns, Physicians' - trends | Drug Prescriptions - statistics & numerical data | Atrial Fibrillation - epidemiology | Antithrombins - economics | Aged | Health Care Surveys | Off-Label Use - statistics & numerical data | Practice Guidelines as Topic
Journal Article
Vaccine, ISSN 0264-410X, 2017, Volume 35, Issue 18, pp. 2329 - 2337
Journal Article
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2010, Volume 376, Issue 9743, pp. 814 - 825
Summary Children who are referred to specialist care with asthma that does not respond to treatment (problematic severe asthma) are a heterogeneous group, with... 
Internal Medicine | SEVERE CHILDHOOD ASTHMA | DIFFICULT ASTHMA | MEDICINE, GENERAL & INTERNAL | RECEPTOR-BINDING-AFFINITY | ALLERGEN EXPOSURE | LUNG-FUNCTION | CYSTIC-FIBROSIS | EXHALED NITRIC-OXIDE | SKIN PRICK TESTS | INNER-CITY CHILDREN | AIRWAY WALL THICKNESS | Bronchodilator Agents - therapeutic use | Allergens - adverse effects | Spirometry | Azathioprine - therapeutic use | Formoterol Fumarate | Off-Label Use | Terbutaline - therapeutic use | Bronchodilator Agents - administration & dosage | Anti-Asthmatic Agents - therapeutic use | Drug Resistance, Multiple | Humans | Bronchial Provocation Tests | Immunoglobulin E | Tomography, X-Ray Computed | Methotrexate - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Asthma - immunology | Asthma - etiology | Drug Therapy, Combination | Child | Asthma - diagnosis | Severity of Illness Index | Asthma - physiopathology | Comorbidity | Risk Factors | Administration, Inhalation | Treatment Outcome | Clinical Trials as Topic | Asthma - drug therapy | Cyclosporine - therapeutic use | Interdisciplinary Communication | Budesonide, Formoterol Fumarate Drug Combination | House Calls | Tobacco Smoke Pollution - adverse effects | Budesonide - therapeutic use | Ethanolamines - therapeutic use | Anti-Asthmatic Agents - administration & dosage | Drug Combinations | Eosinophils | Monoclonal antibodies | Care and treatment | Diagnosis | Research | Asthma in children | Health aspects | Biomarkers | Medical research | Nitric oxide | Asthma
Journal Article